WHO ICTRP trial
Clinical trail on Post Menopausal Syndrome
CTRI/2025/03/082025 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2025/03/082025 |
|---|---|
| Public title | Clinical trail on Post Menopausal Syndrome |
| Scientific title | A prospective, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of VITEX extract in subjects suffering with Post Menopausal Syndrome. - NIL |
| Primary sponsor | Ingex Botanicals Private Limited |
| Secondary sponsors | Bio Actives Japan KK |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3/ Phase 4 |
| Countries | India |
| Interventions | Intervention1: VITEX extract: Dose:300mg Dosing frequency: Capsules Duration:One capsule orally in the morning after breakfast upto 60 days. Control Intervention1: Starch: Dose:300mg Dosing frequency: Capsules Duration: One capsule orally… |
| Registration date | Oct 3, 2025 |
| Target size | 60 |
| Secondary IDs | RRS/CL/PM/VITEX/2024 Version No 1.0 Dated 16 Oct 2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: